Less versus more follow-up after sarcoma surgery
Part of Cancer clinical trials.
This trial compares two schedules of post-treatment check-ups to see which one better supports patient quality of life. You’d fill out surveys for up to two years to measure how you feel over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You finished sarcoma treatment (surgery, chemotherapy, and/or radiation) 8 to 14 weeks before joining
- You are willing to complete health surveys for 2 years
- You do not have cancer that has spread to other organs (no metastatic disease) at the time you enroll
- You can complete the study in English (non-English speaking may not qualify)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares CT scans to chest X-rays to monitor for lung cancer spread after surgery to remove soft tissue sarcoma. If you are at high risk of the sarcoma returning in your lungs, this study helps see which imaging method works better.
This trial compares a shorter course of radiation therapy with the standard longer course for people with soft tissue sarcoma in an arm or leg. The goal is to see if the shorter course works just as well and may be more convenient.
This trial tests a combination of immunotherapy (atezolizumab), chemotherapy (doxorubicin), and radiation before and after surgery for people with high-risk soft tissue sarcoma in the arm, leg, or trunk. The goal is to see if this approach can improve outcomes.
This trial compares different times for surgery after a short course of radiation therapy (preoperative hypofractionated radiotherapy) for soft tissue sarcoma in the arms or legs or on the trunk. It aims to find the best timing to improve outcomes while reducing side effects.
This trial compares two schedules of follow-up imaging (high vs lower intensity) for people who have had surgery for retroperitoneal sarcoma, to see which is better at detecting recurrence without excessive scans.
This study looks at stored tumor tissue (or takes a new biopsy) to measure specific tumor markers. Researchers want to see whether these markers match how well chemotherapy works before surgery for soft-tissue sarcoma.
Hear when a new Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.